We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $150M
1-Year Est. Return 17.71%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+17.71%
3 Year Est. Return
+103.24%
5 Year Est. Return
+155.85%
10 Year Est. Return
+1,056.65%
AUM
$156M
AUM Growth
-$30.1M
Cap. Flow
-$36.6M
Cap. Flow %
-23.54%
Top 10 Hldgs %
67.21%
Holding
35
New
7
Increased
3
Reduced
4
Closed
11

Top Buys

Rank Stock Value
1
CX icon
Cemex
CX
+$6.41M
2
CHDN icon
Churchill Downs
CHDN
+$5.93M
3
BIIB icon
Biogen
BIIB
+$5.89M
4
V icon
Visa
V
+$5.86M
5
HQY icon
HealthEquity
HQY
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 34.46%
2 Consumer Discretionary 27.31%
3 Financials 19.48%
4 Technology 9.11%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
1
Morgan Stanley
MS
$340B
$24.3M 15.6%
136,693
-17,000
-11% -$2.84M
AMZN icon
2
Amazon
AMZN
$2.78T
$15.3M 9.83%
66,271
TEVA icon
3
Teva Pharmaceuticals
TEVA
$42B
$11.5M 7.38%
367,600
-327,400
-47% -$8.07M
NKE icon
4
Nike
NKE
$57.4B
$11.5M 7.36%
179,765
+21,100
+13% +$1.38M
ALC icon
5
Alcon
ALC
$33.5B
$8.53M 5.48%
108,200
+36,566
+51% +$2.82M
CX icon
6
Cemex
CX
$16.1B
$7.12M 4.58%
+620,000
New +$6.41M
UBER icon
7
Uber
UBER
$150B
$6.78M 4.36%
83,036
-15,993
-16% -$1.44M
DXCM icon
8
DexCom
DXCM
$32.2B
$6.76M 4.35%
101,893
+59,893
+143% +$3.87M
CHDN icon
9
Churchill Downs
CHDN
$6.04B
$6.51M 4.18%
+57,179
New +$5.93M
BIIB icon
10
Biogen
BIIB
$32.1B
$6.35M 4.08%
+36,065
New +$5.89M
BMY icon
11
Bristol-Myers Squibb
BMY
$133B
$6.21M 3.99%
+115,179
New +$5.54M
AORT icon
12
Artivion
AORT
$1.24B
$6.05M 3.89%
132,588
V icon
13
Visa
V
$693B
$6.03M 3.88%
+17,200
New +$5.86M
MSFT icon
14
Microsoft
MSFT
$3.66T
$5.95M 3.82%
12,300
HQY icon
15
HealthEquity
HQY
$7.77B
$5.54M 3.56%
+60,484
New +$5.79M
FLUT icon
16
Flutter Entertainment
FLUT
$17B
$5.27M 3.38%
24,484
IBIT icon
17
iShares Bitcoin Trust
IBIT
$60.5B
$4.13M 2.65%
83,119
-20,500
-20% -$1.16M
MLCO icon
18
Melco Resorts & Entertainment
MLCO
$1.97B
$3.96M 2.55%
522,966
MSGS icon
19
Madison Square Garden
MSGS
$9.33B
$3.38M 2.17%
13,072
RXST icon
20
RxSight
RXST
$254M
$1.67M 1.08%
+160,700
New +$1.61M
TOST icon
21
Toast
TOST
$19.2B
$1.43M 0.92%
40,392
CMPS
22
Compass Pathways
CMPS
$1.92B
$1.02M 0.65%
147,209
NEXT icon
23
NextDecade
NEXT
$1.96B
$358K 0.23%
67,837
SRZNW
24
DELISTED
Surrozen Inc Warrant
SRZNW
$8.84K 0.01%
442,052
BBWI icon
25
Bath & Body Works
BBWI
$3.9B
-300,619
Closed -$7.74M

Similar funds

Bridger Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bridger Management held 35 positions worth $156M, down 16% from $186M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bridger Management withdrew a net $36.6M in Q4 2025, closing 11 positions and reducing 4 holdings. Its most notable exit was Citigroup, an estimated $9.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Bridger Management opened a new position in Cemex worth $7.12M.

  • Bridger Management's largest Q4 2025 buy was Cemex: 620,000 shares worth $7.12M.
  • Bridger Management added most to DexCom in Q4 2025, an estimated $3.87M increase.
  • Bridger Management's biggest Q4 2025 reduction was Teva Pharmaceuticals, cutting an estimated $8.07M.
  • Bridger Management fully exited Citigroup in Q4 2025, selling an estimated $9.03M.
  • Bridger Management's ten largest holdings make up 67% of its $156M portfolio in Q4 2025.
  • Bridger Management opened 7 new positions and closed 11 in Q4 2025.
  • Bridger Management's portfolio value fell 16% quarter-over-quarter to $156M.

Based on Bridger Management's 13F filing for Q4 2025, filed 17 Feb 2026.